ENZO BIOCHEM INC Contracts & Agreements

Description of Capital Stock (Filed With SEC on November 3, 2023)

Amendment Agreement by and among JGB Capital, LP, JGB (Cayman) Sussex Ltd., Enzo Biochem, Inc. and JGB Collateral LLC (Filed With SEC on November 3, 2023)

Separation Agreement and General Release between Hamid Erfanian and Enzo Biochem, Inc (Filed With SEC on November 3, 2023)

Settlement Agreement between Barry Weiner, Shahla Weiner, Roya Weiner, and Jonathan Weiner and Enzo Biochem, Inc., Mary Tagliaferri, Ian Walters, Brad Radoff, and Hamid Erfanian (Filed With SEC on November 3, 2023)

Amendment No. 1 to Asset Purchase Agreement, dated as of July 3, 2023, by and among Enzo Biochem, Inc., Enzo Clinical Labs, Inc., and Laboratory Corporation of America Holdings (Filed With SEC on July 10, 2023)

Form of Debenture (Filed With SEC on May 22, 2023)

Form of Warrant (Filed With SEC on May 22, 2023)

Securities Purchase Agreement, dated May 19, 2023, by and among Enzo Biochem, Inc., the purchasers named therein, and JGB Collateral, LLC (Filed With SEC on May 22, 2023)

Registration Rights Agreement, dated May 19, 2023, by and among Enzo Biochem, Inc. and the purchasers named therein (Filed With SEC on May 22, 2023)

Security Agreement, dated May 19, 2023, by and among Enzo Biochem, Inc., each of Enzo Biochem, Inc.s specified subsidiaries named therein, the purchasers named therein and JGB... (Filed With SEC on May 22, 2023)

Form of Subsidiary Guarantee (Filed With SEC on May 22, 2023)

Credit Agreement, dated as of March 31, 2023, by and among Enzo Clinical Labs, Inc., Enzo Life Sciences, Inc., Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL, Enzo... (Filed With SEC on April 5, 2023)

Asset Purchase Agreement, dated as of March 16, 2023, by and among Laboratory Corporation of America Holdings, Enzo Clinical Labs, Inc. and Enzo Biochem, Inc (Filed With SEC on March 16, 2023)

First Amended and Restated Employment Agreement between Enzo Biochem, Inc. and Kara Cannon, effective as of October 20, 2022 (Filed With SEC on November 4, 2022)

Second Amended and Restated Employment Agreement between Enzo Biochem, Inc. and Hamid Erfanian, effective as of October 20, 2022 (Filed With SEC on November 4, 2022)

Sublease agreement between Enzo Biochem, Inc. and Siemens Corporation (Filed With SEC on October 14, 2022)

Employment Agreement between Enzo Biochem, Inc. and David Bench, effective as of March 24, 2022 (Filed With SEC on March 30, 2022)

Employment Agreement between Enzo Biochem, Inc. and Kara Cannon, effective as of March 24, 2022 (Filed With SEC on March 30, 2022)

First Amended and Restated Employment Agreement between Enzo Biochem, Inc. and Hamid Erfanian, effective as of March 24, 2022 (Filed With SEC on March 30, 2022)

Cooperation Agreement, dated January 3, 2022 by and among Enzo Biochem, Inc., Bradley L. Radoff and other parties (Filed With SEC on January 4, 2022)

Executive Employment Agreement between the Company and Hamid Erfanian, dated October 14, 2021 (Filed With SEC on December 15, 2021)

Amended and Restated 2011 Incentive Plan (Filed With SEC on October 19, 2020)

Settlement and License Agreement as of April 16, 2019 among Enzo Life Sciences, Inc., Hologic, Inc., Grifols Diagnostic Solutions Inc., and Grifols, S.A (Filed With SEC on April 22, 2019)

Settlement Agreement as of February 5, 2019 among Enzo Biochem, Inc., Enzo Life Sciences, Inc., Roche Diagnostics GmbH and Roche Molecular Systems, Inc (Filed With SEC on February 11, 2019)

Purchase and Sale Agreement by and between Building Blocks Realty Co. LLC (seller) and Enzo Realty LLC (Purchaser) (Filed With SEC on October 15, 2018)

Amended and Restated 2011 Incentive Plan (Filed With SEC on January 9, 2018)

Enzobiochem, INC. AMENDMENT NO. 1 TO Amendedand restated employment agreement (Filed With SEC on January 10, 2017)

SETTLEMENTAND LICENSE AGREEMENT (Filed With SEC on October 13, 2016)

SETTLEMENTand license AGREEMENT (Filed With SEC on June 8, 2016)

SETTLEMENT AND LICENSE AGREEMENT (Filed With SEC on June 8, 2016)

THIRD AMENDMENT TO REVOLVING LOANAND SECURITY AGREEMENT (Filed With SEC on December 8, 2015)

FIRST AMENDMENT OF LEASE (Filed With SEC on October 13, 2015)

SETTLEMENT AND LICENSE AGREEMENT (Filed With SEC on October 13, 2015)

SETTLEMENT AND LICENSE AGREEMENT (Filed With SEC on September 4, 2015)

ENZO BIOCHEM, INC. CONTROLLED EQUITY OFFERINGSM AMENDMENT NO. 1 TO SALES AGREEMENT (Filed With SEC on December 31, 2014)

SETTLEMENT AGREEMENT (Filed With SEC on October 9, 2014)

SETTLEMENT AGREEMENT (Filed With SEC on June 23, 2014)

ESCROW AGREEMENT (Filed With SEC on June 23, 2014)

SETTLEMENT AGREEMENT (Filed With SEC on April 24, 2014)

ENZO BIOCHEM, INC. Up to $20,000,000 of Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on March 28, 2013)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on October 14, 2010)

ASSET PURCHASE AGREEMENT by and among ENZO LIFE SCIENCES, INC., ENZO LIFE SCIENCES ACQUISITION, INC., ASSAY DESIGNS, INC., AMPERSAND 2001 LIMITED PARTNERSHIP and AMPERSAND 2001... (Filed With SEC on March 13, 2009)

TERMINATION OF SPLIT DOLLAR AGREEMENT (Filed With SEC on August 6, 2008)

STOCK AND ASSET PURCHASE AGREEMENT by and among ENZO BIOCHEM, INC. ENZO LIFE SCIENCES, INC. BIOMOL INTERNATIONAL, INC. AXXORA (UK) LTD. BIOMOL INTERNATIONAL, L.P., BIOFINITI,... (Filed With SEC on May 9, 2008)